| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
19,326 |
17,592 |
$1.24M |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
7,061 |
7,055 |
$519K |
| S9083 |
Global fee urgent care centers |
4,143 |
3,674 |
$501K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,412 |
3,354 |
$332K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
8,081 |
7,419 |
$303K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,868 |
1,736 |
$82K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
540 |
540 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,518 |
1,393 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,178 |
1,104 |
$28K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
264 |
264 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,624 |
1,605 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
227 |
219 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
15 |
15 |
$761.95 |
| 81003 |
|
179 |
178 |
$330.03 |
| 92551 |
|
26 |
26 |
$214.24 |
| 99173 |
|
25 |
25 |
$0.00 |